World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
109
Citations
49687
World Ranking
5724
National Ranking
3077

Overview

Robert R. Henry is affiliated with the University of California, San Diego in the United States. Their research primarily spans the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with a significant focus on Molecular Biology, Physiology, Oncology, Cancer Research, and Epidemiology as subfields.

The scientist's work concentrates on several key topics, including Metabolism, Diabetes, and Cancer, Adipose Tissue and Metabolism, Adipokines, Inflammation, and Metabolic Diseases, Clusterin in disease pathology, Pancreatic function and diabetes, Antioxidant Activity and Oxidative Stress, and Vitamin C and Antioxidants Research.

Robert R. Henry has contributed to a series of scientific papers in notable venues. Recent publications include:

  • Apolipoprotein J is a hepatokine regulating muscle glucose metabolism and insulin sensitivity, 2020, Nature Communications
  • Astaxanthin, a natural antioxidant, lowers cholesterol and markers of cardiovascular risk in individuals with prediabetes and dyslipidaemia, 2023, Diabetes Obesity and Metabolism
  • p300 or CBP is required for insulin-stimulated glucose uptake in skeletal muscle and adipocytes, 2021, JCI Insight
  • Myokine Regulation of Insulin Secretion: Impact of Inflammation and Type 2 Diabetes, 2020, Frontiers in Physiology
  • Author Correction: Apolipoprotein J is a hepatokine regulating muscle glucose metabolism and insulin sensitivity, 2020, Nature Communications

The venues in which Robert R. Henry frequently publishes encompass:

  • Nature Communications
  • Diabetes Obesity and Metabolism
  • JCI Insight
  • Frontiers in Physiology
  • Molecular Biology Reports

Co-authorship collaborations have been regularly established with several researchers, including:

  • Theodore P. Ciaraldi
  • Sunder Mudaliar
  • Ji A Seo
  • Min-Cheol Kang
  • Won-Mo Yang

The scientific contributions by Robert R. Henry reflect a sustained engagement with topics related to metabolic diseases, diabetes, and their molecular underpinnings, as well as the role of antioxidants and inflammation in pathophysiological conditions.

Best Publications

  • Impaired fasting glucose and impaired glucose tolerance: implications for care.

    David M. Nathan;Mayer B. Davidson;Ralph A. DeFronzo;Robert J. Heine

  • Type 2 diabetes mellitus.

    Ralph A. DeFronzo;Ele Ferrannini;Leif Groop;Robert R. Henry

  • Retinol-Binding Protein 4 and Insulin Resistance in Lean, Obese, and Diabetic Subjects

    Timothy E. Graham;Qin Yang;Matthias Blüher;Ann Hammarstedt

  • Effects of Exenatide (Exendin-4) on Glycemic Control Over 30 Weeks in Sulfonylurea-Treated Patients With Type 2 Diabetes

    John B. Buse;Robert R. Henry;Jenny Han;Dennis D. Kim

  • Liraglutide versus glimepiride monotherapy for type 2 diabetes (LEAD-3 Mono): a randomised, 52-week, phase III, double-blind, parallel-treatment trial.

    Alan Garber;Robert Henry;Robert Ratner;Pedro A Garcia-Hernandez

  • Adiponectin: More Than Just Another Fat Cell Hormone?

    Manju Chandran;Susan A. Phillips;Theodore Ciaraldi;Robert R. Henry

  • Acute and chronic effects of insulin on leptin production in humans: Studies in vivo and in vitro.

    Jerzy W Kolaczynski;Mark R Nyce;Robert V Considine;Guenther Boden

  • Efficacy and safety of the farnesoid X receptor agonist obeticholic acid in patients with type 2 diabetes and nonalcoholic fatty liver disease.

    Sunder Mudaliar;Robert R. Henry;Arun J. Sanyal;Linda Morrow

  • The expression of TNF alpha by human muscle. Relationship to insulin resistance.

    M Saghizadeh;J M Ong;W T Garvey;R R Henry

  • CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM--2016 EXECUTIVE SUMMARY.

    Alan J. Garber;Martin J. Abrahamson;Joshua I. Barzilay;Lawrence Blonde

  • SGLT2 inhibition — a novel strategy for diabetes treatment

    Edward C. Chao;Robert R. Henry

  • Pioglitazone for Diabetes Prevention in Impaired Glucose Tolerance

    Ralph A. DeFronzo;Devjit Tripathy;Dawn C. Schwenke;Dawn C. Schwenke;Mary Ann Banerji

  • American association of clinical endocrinologists and american college of endocrinology - clinical practice guidelines for developing a diabetes mellitus comprehensive care plan - 2015.

    Yehuda Handelsman;Zachary T. Bloomgarden;George Grunberger;Guillermo Umpierrez

  • Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity.

    Harold E Bays;J Michael González-Campoy;George A Bray;Abbas E Kitabchi

  • Poor medication adherence in type 2 diabetes: recognizing the scope of the problem and its key contributors

    William H Polonsky;Robert R Henry

  • Can a Shift in Fuel Energetics Explain the Beneficial Cardiorenal Outcomes in the EMPA-REG OUTCOME Study? A Unifying Hypothesis

    Sunder Mudaliar;Sindura Alloju;Robert R Henry

  • Normal insulin-dependent activation of Akt/protein kinase B, with diminished activation of phosphoinositide 3-kinase, in muscle in type 2 diabetes

    Young Bum Kim;Svetlana E. Nikoulina;Theodore P. Ciaraldi;Robert R. Henry

  • Effects of Varying Carbohydrate Content of Diet in Patients With Non—Insulin-Dependent Diabetes Mellitus

    Abhimanyu Garg;John P. Bantle;Robert R. Henry;Robert R. Henry;Ann M. Coulston

  • Potential role of glycogen synthase kinase-3 in skeletal muscle insulin resistance of type 2 diabetes.

    S E Nikoulina;T P Ciaraldi;S Mudaliar;P Mohideen

  • Effects of Weight Loss on Mechanisms of Hyperglycemia in Obese Non-Insulin-Dependent Diabetes Mellitus

    R R Henry;P Wallace;J M Olefsky

Frequent Co-Authors

Sunder Mudaliar
Sunder Mudaliar University of California, San Diego
Jerrold M. Olefsky
Jerrold M. Olefsky University of California, San Diego
Ralph A. DeFronzo
Ralph A. DeFronzo The University of Texas Health Science Center at San Antonio
George A. Bray
George A. Bray Louisiana State University
Abbas E. Kitabchi
Abbas E. Kitabchi University of Tennessee Health Science Center
Julio Rosenstock
Julio Rosenstock The University of Texas Southwestern Medical Center
Thomas A. Buchanan
Thomas A. Buchanan University of Southern California
Russell S. Richardson
Russell S. Richardson University of Utah
John B. Buse
John B. Buse University of North Carolina at Chapel Hill
Robert E. Ratner
Robert E. Ratner Georgetown University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring healthcare careers doesn’t always mean attending medical school. Many students and professionals pursue alternative pathways through accredited online programs, which offer flexibility and cost savings.

For example, if you’re interested in administrative roles, understanding how much does it cost to become a medical coder can help you gauge this as a potential entry point into healthcare. Medical coding and billing programs are often affordable and can be completed in less than a year.

For those seeking direct patient care, nursing remains in high demand. If cost is a concern, research what is the cheapest online college for nursing? to compare accredited options, or consider the cheapest online np programs if you’re aiming to take on more advanced nursing roles.

For experienced nurses who want to advance their expertise further, an online phd in nursing opens doors to leadership, education, and research positions.

Each of these online degrees and certifications can help you begin or advance your career in the healthcare sector, even if traditional medical school isn’t the right fit.

Best Scientists Citing Robert R. Henry

Trending Scientists

Recently Published Articles